Back to KROS
FMR LLC KROS Position History
Keros Therapeutics, Inc. • Healthcare
Quarters held
45
Latest value
$34
Q3 2026
Peak value
$288.7M
First seen
Q1 2022
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2022 | $163.6M |
| Q1 2022 | $16K |
| Q2 2022 | $99.5M |
| Q2 2022 | $11K |
| Q3 2022 | $144.3M |
| Q3 2022 | $406K |
| Q3 2022 | $653K |
| Q4 2022 | $175.4M |
| Q4 2022 | $518K |
| Q4 2022 | $796K |
| Q1 2023 | $171.8M |
| Q1 2023 | $461K |
| Q1 2023 | $725K |
| Q2 2023 | $161.9M |
| Q2 2023 | $506K |
| Q2 2023 | $736K |
| Q3 2023 | $113.9M |
| Q3 2023 | $402K |
| Q3 2023 | $637K |
| Q4 2023 | $143.2M |
| Q4 2023 | $7.8M |
| Q4 2023 | $3.1M |
| Q1 2024 | $288.7M |
| Q1 2024 | $21.6M |
| Q1 2024 | $21.9M |
| Q2 2024 | $182.8M |
| Q2 2024 | $17.1M |
| Q2 2024 | $15.8M |
| Q3 2024 | $240.4M |
| Q3 2024 | $918 |
| Q3 2024 | $21.7M |
| Q3 2024 | $22.4M |
| Q4 2024 | $71.9M |
| Q4 2024 | $263 |
| Q4 2024 | $7M |
| Q4 2024 | $8.9M |
| Q1 2025 | $4.5M |
| Q3 2025 | $1.6M |
| Q3 2025 | $892 |
| Q4 2025 | $725K |
| Q4 2025 | $129 |
| Q1 2026 | $361K |
| Q2 2026 | $378K |
| Q3 2026 | $296K |
| Q3 2026 | $34 |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $34 | 3 | — | — |
| Q3 2026 | $296K | 25.9K | — | — |
| Q2 2026 | $378K | 35.3K | — | — |
| Q1 2026 | $361K | 32.7K | — | — |
| Q4 2025 | $129 | 6 | — | — |
| Q4 2025 | $725K | 35.6K | — | — |
| Q3 2025 | $892 | 56 | — | — |
| Q3 2025 | $1.6M | 100.5K | — | — |
| Q1 2025 | $4.5M | 441.5K | — | — |
| Q4 2024 | $8.9M | 562.0K | — | — |
| Q4 2024 | $7M | 441.9K | — | — |
| Q4 2024 | $263 | 17 | — | — |
| Q4 2024 | $71.9M | 4.54M | — | — |
| Q3 2024 | $22.4M | 386.3K | — | — |
| Q3 2024 | $21.7M | 373.0K | — | — |
| Q3 2024 | $918 | 16 | — | — |
| Q3 2024 | $240.4M | 4.14M | — | — |
| Q2 2024 | $15.8M | 346.6K | — | — |
| Q2 2024 | $17.1M | 373.7K | — | — |
| Q2 2024 | $182.8M | 4.00M | — | — |
| Q1 2024 | $21.9M | 331.4K | — | — |
| Q1 2024 | $21.6M | 326.0K | — | — |
| Q1 2024 | $288.7M | 4.36M | — | — |
| Q4 2023 | $3.1M | 77.5K | — | — |
| Q4 2023 | $7.8M | 195.3K | — | — |
| Q4 2023 | $143.2M | 3.60M | — | — |
| Q3 2023 | $637K | 20.0K | — | — |
| Q3 2023 | $402K | 12.6K | — | — |
| Q3 2023 | $113.9M | 3.57M | — | — |
| Q2 2023 | $736K | 18.3K | — | — |
| Q2 2023 | $506K | 12.6K | — | — |
| Q2 2023 | $161.9M | 4.03M | — | — |
| Q1 2023 | $725K | 17.0K | — | — |
| Q1 2023 | $461K | 10.8K | — | — |
| Q1 2023 | $171.8M | 4.02M | — | — |
| Q4 2022 | $796K | 16.6K | — | — |
| Q4 2022 | $518K | 10.8K | — | — |
| Q4 2022 | $175.4M | 3.65M | — | — |
| Q3 2022 | $653K | 17.4K | — | — |
| Q3 2022 | $406K | 10.8K | — | — |
| Q3 2022 | $144.3M | 3.84M | — | — |
| Q2 2022 | $11K | 403 | — | — |
| Q2 2022 | $99.5M | 3.60M | — | — |
| Q1 2022 | $16K | 297 | — | — |
| Q1 2022 | $163.6M | 3.01M | — | — |